Bcwm LLC Has $3.98 Million Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Bcwm LLC lifted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.2% during the 2nd quarter, Holdings Channel reports. The fund owned 42,915 shares of the exchange traded fund’s stock after acquiring an additional 1,742 shares during the quarter. Bcwm LLC’s holdings in SPDR S&P Biotech ETF were worth $3,979,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Avoro Capital Advisors LLC bought a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $396,844,000. Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of SPDR S&P Biotech ETF by 30.3% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after purchasing an additional 730,000 shares in the last quarter. Jane Street Group LLC grew its stake in shares of SPDR S&P Biotech ETF by 68.7% during the first quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock valued at $91,197,000 after purchasing an additional 391,333 shares during the last quarter. Bessemer Group Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 1.7% in the first quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock valued at $87,572,000 after purchasing an additional 15,794 shares in the last quarter. Finally, Mirae Asset Securities USA Inc. bought a new position in SPDR S&P Biotech ETF in the 2nd quarter worth approximately $55,626,000.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA:XBI opened at $101.21 on Monday. The company has a market cap of $7.71 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The stock’s fifty day moving average price is $98.48 and its two-hundred day moving average price is $93.85. SPDR S&P Biotech ETF has a 52-week low of $63.80 and a 52-week high of $103.52.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.